© 2001 by Oxford University Press
Journal of the National Cancer Institute, Vol. 93, No. 8, 640-644,
April 18, 2001
© 2001 Oxford University Press
REPORT |
Familial Risk of Pancreatic Cancer
Affiliations of authors: M. Schenk, Epidemiology Section, Barbara Ann Karmanos Cancer Institute, and Department of Family Medicine, Wayne State University, Detroit, MI; A. G. Schwartz, Epidemiology Section, Barbara Ann Karmanos Cancer Institute, and Department of Internal Medicine, Wayne State University; E. O'Neal, Epidemiology Section, Barbara Ann Karmanos Cancer Institute; M. Kinnard, Department of Environmental Health Sciences, University of Michigan School of Public Health, Ann Arbor, and Division of Gastroenterology, Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH; J. K. Greenson, Department of Pathology, University of Michigan School of Medicine, Ann Arbor; J. P. Fryzek, Department of Environmental Health Sciences, University of Michigan School of Public Health, and International Epidemiology Institute, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN; G. S. Ying, Departments of Environmental Health Sciences and Biostatistics, University of Michigan School of Public Health; D. H. Garabrant, Department of Environmental Health Sciences, University of Michigan School of Public Health.
Correspondence to: Maryjean Schenk, M.D., M.P.H., Epidemiology Section, Barbara Ann Karmanos Cancer Institute, 110 E. Warren Ave., Detroit, MI 48201 (e-mail: mschenk{at}med.wayne.edu).
Background: Pancreatic cancer is the fifth leading cause of cancer-related mortality in the United States. Although smoking and age are known risk factors for pancreatic cancer, several case reports and case–control studies have suggested that there is also a familial risk. We evaluated whether a family history of pancreatic cancer increases the risk of pancreatic cancer in first-degree relatives and whether smoking and younger age at cancer diagnosis further increase this risk. Methods: We conducted in-person interviews with 247 patients ("case probands") with pancreatic cancer and 420 population-based control probands to collect risk factor data and pancreatic cancer family history for 1816 first-degree relatives of the case probands and 3157 first-degree relatives of the control probands. We analyzed the data by unconditional logistic regression models, with adjustment for correlated data by use of generalized estimating equations. All statistical tests were two-sided. Results: A positive family history of pancreatic cancer (i.e., being related to a case proband) or ever-smoking cigarettes approximately doubled the risk of pancreatic cancer (relative risk [RR] = 2.49; 95% confidence interval [CI] = 1.32 to 4.69; RR = 2.04; 95% CI = 1.09 to 3.83, respectively). The RR increased to 8.23 (95% CI = 2.18 to 31.07) for relatives who ever smoked and were related to a case proband who was diagnosed before age 60 years. Conclusion: Routine questioning of patients about a family history of pancreatic cancer, the age of onset of this cancer in their relatives, and the patient's smoking status may identify individuals at high risk of pancreatic cancer. Future research exploring the genetic and environmental interactions associated with the risk of pancreatic cancer is critically important.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  F. J. Couch, X. Wang, R. R. McWilliams, W. R. Bamlet, M. de Andrade, and G. M. Petersen Association of Breast Cancer Susceptibility Variants with Risk of Pancreatic Cancer Cancer Epidemiol. Biomarkers Prev., November 1, 2009; 18(11): 3044 - 3048. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. M. Wolpin, A. T. Chan, P. Hartge, S. J. Chanock, P. Kraft, D. J. Hunter, E. L. Giovannucci, and C. S. Fuchs ABO Blood Group and the Risk of Pancreatic Cancer J Natl Cancer Inst, March 18, 2009; 101(6): 424 - 431. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. E Brand, M. M Lerch, W. S Rubinstein, J. P Neoptolemos, D. C Whitcomb, R. H Hruban, T. A Brentnall, H. T Lynch, M. I Canto, and Participants of the Fourth International Symposium Advances in counselling and surveillance of patients at risk for pancreatic cancer Gut, October 1, 2007; 56(10): 1460 - 1469. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Raimondi, P. Maisonneuve, J-M. Lohr, and A. B. Lowenfels Early Onset Pancreatic Cancer: Evidence of a Major Role for Smoking and Genetic Factors Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1894 - 1897. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B Greer and D. C Whitcomb Role of BRCA1 and BRCA2 mutations in pancreatic cancer Gut, May 1, 2007; 56(5): 601 - 605. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. J. Couch, M. R. Johnson, K. G. Rabe, K. Brune, M. de Andrade, M. Goggins, H. Rothenmund, S. Gallinger, A. Klein, G. M. Petersen, et al. The Prevalence of BRCA2 Mutations in Familial Pancreatic Cancer Cancer Epidemiol. Biomarkers Prev., February 1, 2007; 16(2): 342 - 346. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. F. Hezel, A. C. Kimmelman, B. Z. Stanger, N. Bardeesy, and R. A. DePinho Genetics and biology of pancreatic ductal adenocarcinoma. Genes & Dev., May 15, 2006; 20(10): 1218 - 1249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Petersen, M. de Andrade, M. Goggins, R. H. Hruban, M. Bondy, J. F. Korczak, S. Gallinger, H. T. Lynch, S. Syngal, K. G. Rabe, et al. Pancreatic cancer genetic epidemiology consortium. Cancer Epidemiol. Biomarkers Prev., April 1, 2006; 15(4): 704 - 710. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Fryzek, M. Schenk, M. Kinnard, J. K. Greenson, and D. H. Garabrant The Association of Body Mass Index and Pancreatic Cancer in Residents of Southeastern Michigan, 1996-1999 Am. J. Epidemiol., August 1, 2005; 162(3): 222 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. J. Couch, M. R. Johnson, K. Rabe, L. Boardman, R. McWilliams, M. de Andrade, and G. Petersen Germ Line Fanconi Anemia Complementation Group C Mutations and Pancreatic Cancer Cancer Res., January 15, 2005; 65(2): 383 - 386. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Ghiorzo, L. Pastorino, L. Bonelli, R. Cusano, A. Nicora, S. Zupo, P. Queirolo, M. Sertoli, V. Pugliese, and G. Bianchi-Scarra INK4/ARF germline alterations in pancreatic cancer patients Ann. Onc., January 1, 2004; 15(1): 70 - 78. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. A. Risch Etiology of Pancreatic Cancer, With a Hypothesis Concerning the Role of N-Nitroso Compounds and Excess Gastric Acidity J Natl Cancer Inst, July 2, 2003; 95(13): 948 - 960. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Inoue, K. Tajima, T. Takezaki, N. Hamajima, K. Hirose, H. Ito, and S. Tominaga Epidemiology of pancreatic cancer in Japan: a nested case-control study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC) Int. J. Epidemiol., April 1, 2003; 32(2): 257 - 262. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. B. Lowenfels, P. Maisonneuve, D. C. Whitcomb, M. M. Lerch, and E. P. DiMagno Cigarette Smoking as a Risk Factor for Pancreatic Cancer in Patients With Hereditary Pancreatitis JAMA, July 11, 2001; 286(2): 169 - 170. [Full Text] [PDF]
|
|